Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Tirzepatide starts at 2.5 mg and climbs to 5, 7.5, 10, 12.5, and 15 mg across about 20 weeks
A subcutaneous (SC) injection takes a slightly different approach
"The best way to predict your future is to create it through the small, consistent choices you make every day." Take the next step in your wellness journey by prioritizing quality
Always check for any changes in color or clarity, as this can indicate degradation
Who Might Consider BPC-157 and Who Should Avoid It Based on the preclinical data and clinical patterns of use, the patient populations most commonly prescribed BPC-157 for GI indications include: patients with persistent NSAID gastropathy despite PPI therapy, patients with functional GI symptoms attributed to intestinal barrier dysfunction, and patients with inflammatory bowel disease who have not responded adequately to biologic therapy and seek adjunctive options
)
